- US11845755utility2023Compounds and Methods for Treatment of Viral Infections0 cites
- US11833143utility2023Choline Salt Forms of an HIV Capsid Inhibitor0 cites
- US11833150utility2023Methods of Treating Liver Disease0 cites
- US11827609utility2023Toll Like Receptor Modulator Compounds0 cites
- US11827662utility2023Cot Modulators and Methods of Use Thereof0 cites
- US11814406utility2023Compounds and Methods for Treatment of Viral Infections0 cites
- US11807625utility2023Capsid Inhibitors for the Prevention of HIV0 cites
- US11795210utility2023HIV Vaccines and Methods of Making and Using0 cites
- US11787825utility2023Therapeutic Compounds for HIV Virus Infection0 cites
- US11787832utility20232′-substituted Carba-nucleoside Analogs for Antiviral Treatment0 cites
- US11780844utility2023Compounds and Methods for Treatment of Viral Infections0 cites
- US11773098utility2023Solid Forms of a Toll-like Receptor Modulator0 cites
- US11773122utility2023Phospholipid Compounds and Uses Thereof0 cites
- US11767337utility2023Antiviral Compounds0 cites
- US11760736utility2023Processes and Intermediates for Preparing MCL1 Inhibitors0 cites
- US11760746utility2023Methods and Intermediates for Preparing Therapeutic Compounds0 cites
- US11753399utility2023Therapeutic Compounds0 cites
- US11744802utility2023Therapeutic Compositions for Treatment of Human Immunodeficiency Virus0 cites
- US11738013utility2023Methods for Treating Hepatitis B Virus Infections Using NS5A, NS5B or NS3 Inhibitors0 cites
- US11739065utility2023FXR (NR1H4) Modulating Compounds0 cites